Nulojix
Nulojix (belatacept) is a selective T cell co-stimulation blocker. It is used with other drugs to prevent kidney transplant rejection. Nulojix works by weakening the body’s immune system to help prevent rejection.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
MANUFACTURER: Bristol Myers Squibb |
CLASS: T cell blocker |
WHAT IT TREATS:
|
PRESCRIBED BY: Nephrologists (kidney doctors) |
HOW ADMINISTERED: IV infusion |
FREQUENCY: Day 1, day 5, week 2, week 4 then every 4 weeks |
Length of infusion: About 30 minutes |
FOR MORE INFORMATION: |
